Acute versus chronic graft rejection: Related manifestations of allosensitization in graft recipients

Transplantation Reviews

Volumn 11, Issue 1, 1997, Pages 38-50

  Orosz, Charles G ^a   Bergese, Sergio D ^a   Wakely, Elaine ^a   Xia, Dongyuan ^a   Gordillo, Gayle M ^a   VanBuskirk, Anne M ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002651032     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-470X(97)80036-5     Document Type: Article

References (75)

1. Hall BM: Cells mediating allograft rejection. Transplantation 1991, 51:1141
2. Rosenberg AS, Singer A: Cellular basis of skin allograft rejection: An in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 1992, 10:333
3. Bradley JA, Bolton EM: The T cell requirements for allograft rejection. Transplant Rev 1992, 6:115
4. Paul CP, Benediktsson H: Chronic Transplant Rejection: Magnitude of the Problem and Pathogenetic Mechanisms. Transplant Rev 1993, 7:96
5. Hayry P, Mennander A, Yilmaz S, et al: Towards understanding the pathophysiology of chronic rejection. Clin Investig 1992, 70:1
6. Almond PS, Matas A, Gillingham K, et al: Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993, 55:752
7. Ferguson R: Acute rejection episodes-best predictor of long-term primary cadaveric renal transplant survival. Clin Transpl 1994, 8:328
8. Isoniemi H, Nurminen M, Tikkanen MJ, et al: Risk factors predicting chronic rejection of renal allografts. Transplantation 1994, 57:68
9. Matas AJ, Gillingham KJ, Payne WD, et al: The Impact of an Acute Rejection Episode on Long-Term Renal Allograft Survival (t1/2). Transplantation 1994, 57:857
10. Mennander A, Raisanen A, Paavonen T, et al: Chronic rejection in the rat aortic allograft. Transplantation 1993, 55:124
11. Russell PS, Chase CM, Winn HJ, et al: Coronary atherosclerosis in transplanted mouse hearts. 1. Time course and immunogenetic and immunopathological considerations. Am J Pathol 1994, 144:260
12. Madsen JC, Peugh WN, Wood KJ, et al: The Effect of Anti-L3T4 Monoclonal Antibody Treatment on First-Set Rejection of Murine Cardiac Allografts. Transplantation 1987, 44:849
13. Darby CR, Morris PJ, Wood KJ: Evidence that long-term cardiac allograft survival induced by anti-CD4 monoclonal antibody does not require depletion of CD4+ cells. Transplantation 1992, 54:483
14. Isobe M, Yagita H, Okumura K, et al: Specific Acceptance of Cardiac Allograft After Treatment with Antibodies to ICAM-1 and LFA-1. Science 1992, 255:1125
15. Isobe M, Suzuki J, Yagita H, et al: Effect of Anti-VCAM-1 and Anti-VLA-4 Monoclonal Antibodies on Cardiac Allograft Survival and Response to Soluble Antigens in Mice. Transplantation Proceedings 1994, 26:867
16. Orosz CG, Ohye RG, Pelletier RP, et al: Treatment with Anti-VCAM-1 mAb Induces Long Term Murine Cardiac Allograft Acceptance. Transplantation 1993, 56:453
17. Pearson TC, Alexander DZ, Winn KJ, et al: Transplantation Tolerance Induced by CTLA4-Ig. Transplantation 1994, 57: 1701
18. Larsen CP, Alexander DZ, Hollenbaugh D, et al: CD10-gp39 interactions play a critical role during allograft rejection. Transplantation 1996, 61:4
19. Chavin KD, Qin L, Lin J, et al: Combined Anti-CD2 and Anti-CD3 Receptor Monoclonal Antibodies Induce Donor-Specific Tolerance in a Cardiac Transplant Model. J Immunol 1993, 151:7249
20. Orosz CG, Wakely E, Bergese SD, et al: Prevention of murine cardiac allograft rejection with gallium nitrate: Comparison with anti-CD4 mAb. Transplantation 1996, 61:783
21. Chace JH, Cowdery JS, Field EH: Effect of anti-CD4 on CD4 subsets. I. Anti-CD4 preferentially deletes resting, naive CD4 cells and spares activated CD4 cells. J Immunol 1994, 152:405
22. Alters SE, Shizuru A, Ackerman J, et al: Anti-CD4 mediates clonal anergy during transplantation tolerance induction. J Exp Med 1991, 173:491
23. Mazcrolles F, Auffray C, Fischer A: Down regulation of T-cell adhesion by CD4. Hum Immunol 1991, 31:40
24. Pelletier RP, Morgan CJ, Sedmak DD, et al: Analysis of Inflammatory Endothelial Changes, Including VCAM-1 Expression, In Murine Cardiac Grafts. Transplantation 1993, 55:315
25. Bergese SD, Huang EH, Pelletier RP, et al: Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Expression of allograft endothelial VCAM-1 can be manipulated with antagonist of IFN-a or IL-4 and is not required for allograft rejection. Am J Pathol 1995, 147:166
26. Leppink DM, Bishop DK, Scdmak DD, et al: Inducible expression of an endothelial cell antigen on murine myocardial vasculature in association with interstitial cellular infiltration. Transplantation 1989, 48:874
27. Morgan CJ, Pelletier RP, Hernandez CJ, et al: Alloantigen-Dependent Endothelial Fhenotype and Lymphokine mRNA Expressions in Rejecting Murine Cardiac Allografts. Transplantation 1993, 55:919
28. Russell ME, Adams DH, Wyner LR, et al: Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts. Proc Natl Acad Sci USA 1993, 90:6086
29. Dallman MJ, Larsen CP, Morris PJ: Cytokine Gene Transcription in Vascularised Organ Grafts: Analysis Using Semiquantitative Polymerase Chain Reaction. J Exp Med 1991, 174:493
30. Rose ML: Antibody-Mediated Rejection Following Cardiac Transplantation. Transplant Rev 1993, 7:140
31. Kajstura J, Cheng W, Reiss K, et al: Apoptotic and necrotic myocyte cell deaths arc independent contributing variables of infarct size in rats. Lab Invest 1996, 74:86
32. Orosz CG, Wakely E, Scdmak DD, et al: Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 mAb. Transplantation 1997, (in press)
33. Bugeon L, Cuturi M-C, Hallet M-M, et al: Peripheral tolerance of an allograft in adult rats-characterization by low interleukin-2 and interferon-gamma mRNA levels and by-strong accumulation of major histocompatibility complex transcripts in the graft. Transplantation 1992, 54:219
34. Salom RN, Maguire JA, Hancock WW: Mechanism of a Clinically Relevant Protocol to Induce Tolerance of Cardiac Allografts. Transplantation 1993, 56:1309
35. Cramer DV, Wu G-D, Chapman FA, et al: Lymphocytic subsets and histopathologic changes associated with the development of heart transplant arteriosclerosis. J Heart Lung Transpl 1992, 11:458
36. Ardehali A, Laks H, Drinkwater DC, et al: Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy. Circulation 1995, 92:450
37. Takeuchi T, Lowry RP, Konieczny B: Heart allografts in murine systems. The Differential Activation of Th2-like Effector Cells in Peripheral Tolerance. Transplantation 1992, 53:1281
38. Thyberg J, Blomgren K, Hedin U, et al: Phenotypic modulation of smooth muscle cells during the formation of neointimal thickenings in the rat carotid artery after balloon injury: An electron-microscopic and stereological study. Cell Tissue Res 1995, 281:421
39. Myers PR: Vaxcular wound healing and restenosis following revascularization, in Weber KT (ed): Wound healing in cardiovascular disease. Armonk, NY, Futura Publishing Company, 1995, 137
40. Libby P, Schwartz D, Brogi E, et al: A cascade model for restenosis. A special case of atherosclerosis progression. Circulation 1992, 86:47 (suppl 6)
41. Davies MG, Hagen PO: Structural and functional consequences of bypass grafting with autologous vein. Cryobiology 1994, 31:63
42. Tullius SG, Tilney NL: Both alloantigen-dependent and independent factors influence chronic allograft rejection. Transplantation 1995, 59:313
43. Tullius SG, Hancock WW, Heemann UW: Long-term kidney isografts develop functional and morphological changes which mimic those of chronic allograft rejection. Ann Surg 1994, 220:425
44. Yilmaz S, Paavonen T, Hayry P: Chronic Rejection of Rat Renal Allografts. Transplantation 1992, 53:823
45. Anderson HO, Holm P, Stender S, et al: Relative importance of ischemic injury and immunological injury on the development of transplant arteriosclerosis in rabbit aortic allografts. Transplantation 1995, 60:631
46. Orosz CG: Local cellular immunology of experimental transplant vascular sclerosis. Clin Transpl 1996, 10:100
47. Koskinen PK, Lemstrom KB, Hayry PJ: How cyclosporin modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts. Am J Pathol 1995, 146:972
48. Roberts JP, Lake JR, Hebert M, et al: Reversal of chronic rejection after treatment failure with FK506 and RS61443. Transplantation 1993, 56:1021
49. Orloff MS, DeMara EM, Coppage MI, et al: Prevention of Chronic Rejection and Graft Arteriosclerosis by Tolerance Induction. Transplantation 1995, 59:282
50. Swan SK, Crary GS, Guijarro C, et al: Immunosuppressive effects of leflunomide in experimental chronic vascular rejection. Transplantation 1995, 60:887
51. Shin YT, Adams DH, Wyner LR, et al: Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model. Transplantation 1995, 59:1617
52. Larsen CP, Elwood ET, Alenander DZ, et al: Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996, 381:434
53. Handa N, Hatanaka M, Baumgartner WA, et al: Late Cyclosporin Treatment Ameliorates Established Coronary Graft Disease in Rat Allografts. Transplantation 1993, 56:525
54. Koskinen PK, Nieminen MS, Krogerus LA, et al: Cytomegalovirus Infection Accelerates Cardiac Allograft Vasculopathy: Correlation Between Angiographic and Endomyocardial Biopsy Findings in Heart Transplantation. Trans Int 1993, 6:341
55. Eich D, Thompson JA, Ko DJ, et al: Hypercholesterolemia in long-term survivors of heart transplantation: an early marker of accelerated coronary artery disease. J Heart Lung Transpl 1991, 10:45
56. Raisanen-Sokolowski A, Tilly-Kiesi M, Ustinov J, et al: Hyperlipidemia accelerates allograft arteriosclerosis (chronic rejection) in the rat. Arterio & Thromb 1994, 14:2032
57. Katsuda S, Nakanishi I: The pathogenesis of atherosclerosis, in Weber KT (ed): Wound Healing in Cardiovascular disease. Armonk, NY, Futura, 1995, 179
58. Nabel EG, Shum L, Pompili VJ, et al: Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci USA 1993, 90:10759
59. Daynes RA, Dowell T, Araneo BA: Platelet-derived growth factor is a potent biologic response modifier of T cells. J Exp Med 1991, 174:1323
60. Lee H-M, Rich S: Differential activation of CD8+ T cells by transforming growth factor-b1. J Immunol 1993, 151:668
61. Zhao X-M, Byrd VM, McKeehan WL, et al: Costimulation of human CD4+ T cells by fibroblast growth factor-1 (acidic fibroblast growth factor). J Immunol 1995, 155:3904
62. Peoples GE, Blotnick S, Takahashi K, et al: T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-bnding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. Proc Natl Acad Sci USA 1995, 92:6547
63. Chen Y, Kuchroo VK, Inobe J-I, et al: Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune Encephalomyelitis. Science 1994, 265:1237
64. Raghow R: The Role of Extracellular Matrix in Postinflammatory Wound Healing and Fibrosis. FASEB J 1994, 8:823
65. Goetzel EJ, Banda MJ, Leppert D: Matrix metalloproteinases in immunity. J Immunol 1996, 156:1
66. Wagner CR, Morris TE, Shipley GD, et al: Regulation of human aortic endothelial cell-derived mesenchymal growth factors by allogeneic lymphocytes in vitro. A potential mechanism for cardiac allograft vasculopathy. J Clin Invest 1993, 92:1269
67. Russell PS, Chase CM, Winn HJ, et al: Coronary Atherosclerosis in Transplanted Mouse Hearts. H. Importance of Humoral Immunity. J Immunol 1991, 152:5135
68. Halloran PF, Schlaut J, Solez K, et al: The Significance of the Anti-Class I Response. II. Clinical and pathologic features of renal transplants with anti-class 1-like antibody. Transplantation 1992, 53:550
69. Lobo PI, Spencer CE, Stevenson WC, et al: Evidence demonstrating poor kidney graft survival when acute rejections are associated with IgG donor-specific lymphocytotoxin. Transplantation 1995, 59:357
70. Tullius SG, Hancock WW, Heemann U, et al: Reversibility of Chronic Renal Allograft Rejection. Transplantation 1994, 58:93
71. Gregory CR, Huang X, Pratt RE, et al: Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. Transplantation 1995, 59:655
72. Gregory CR, Huie P, Billingham ME, et al: Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine responses in injured vessels. Transplantation 1993, 55:1409
73. Marx SO, Jayaraman T, Go LO, et al: Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 1995, 76:112
74. Santoian ED, Schneider JE, Gravanis MB, et al: Angiopeptin inhibits intimal hyperplasia after angioplasty in porcine coronary arteries. Circulation 1993, 88:11
75. Wahlers T, Mugge A, Oppelt P, et al: Preventive treatment of coronary vasculopathy in heart transplantation by inhibition of smooth muscle cell proliferation with angiopeptin. J Heart Lung Transpl 1995, 14(1 Pt 1):143